Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04059484
What this trial is testing

Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Sanofi 367
Testing effectiveness (Phase 2)Study completedNCT04258033
What this trial is testing

PLB1001 in Non-small Cell Lung Cancer With c-Met Dysregulation(KUNPENG)

Who this might be right for
Non-small Cell Lung Cancer
Beijing Pearl Biotechnology Limited Liability Company 145
Early research (Phase 1)Study completedNCT07308652
What this trial is testing

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 764198 in the Blood

Who this might be right for
Healthy
Boehringer Ingelheim 14
Early research (Phase 1)Active Not RecruitingNCT05717348
What this trial is testing

ES014 in Patients With Locally Advanced or Metastatic Solid Tumours

Who this might be right for
Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor
Elpiscience (Suzhou) Biopharma, Ltd. 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05064878
What this trial is testing

Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.

Who this might be right for
CDKL5 Deficiency DisorderGeneralized Tonic Clonic SeizureEpileptic Spasm+1 more
Zogenix, Inc. 87
Not applicableStudy completedNCT02198885
What this trial is testing

Comparing Use of a Prehospital Ultrasound System and Standard Prehospital Care in Thoracoabdominal Trauma

Who this might be right for
Thoracoabdominal TraumaFocused Assessment With Sonography for Trauma (FAST)NanoMaxx Ultrasound System (SonoSite)+1 more
University of Saskatchewan 12
Large-scale testing (Phase 3)Study completedNCT00717678
What this trial is testing

Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationTransplantation ImmunologyHost vs Graft Reaction
Astellas Pharma Inc 73
Large-scale testing (Phase 3)Study completedNCT01183143
What this trial is testing

Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization

Who this might be right for
InfertilityOvulation InductionIn-Vitro Fertilization
Merck KGaA, Darmstadt, Germany 215
Testing effectiveness (Phase 2)Ended earlyNCT02239835
What this trial is testing

Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 79
Early research (Phase 1)Study completedNCT05255276
What this trial is testing

PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor.

Who this might be right for
Healthy Adults
Mirati Therapeutics Inc. 36
Large-scale testing (Phase 3)Ended earlyNCT03504917
What this trial is testing

Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension

Who this might be right for
Autism Spectrum Disorder
Hoffmann-La Roche 322
Large-scale testing (Phase 3)Study completedNCT02604017
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 703
Early research (Phase 1)Ended earlyNCT02058017
What this trial is testing

OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy

Who this might be right for
Nasopharyngeal Carcinoma
National University Hospital, Singapore 9
Early research (Phase 1)Study completedNCT01007968
What this trial is testing

Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 25
Early research (Phase 1)Study completedNCT00957268
What this trial is testing

Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 46
Not applicableNot Yet RecruitingNCT06708650
What this trial is testing

Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaRadiotherapyPD-1 Inhibitors
Guiping People's Hospital 50
Early research (Phase 1)Active Not RecruitingNCT04526691
What this trial is testing

Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

Who this might be right for
Advanced or Metastatic NSCLC
Daiichi Sankyo 145
Post-approval studies (Phase 4)Study completedNCT06331715
What this trial is testing

Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg

Who this might be right for
Bioequivalence
Megalabs 24
Early research (Phase 1)Study completedNCT05677035
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LINO-1713 in Healthy Korean Female Subjects

Who this might be right for
Contraception
Hyundai Pharm 20
Testing effectiveness (Phase 2)Looking for participantsNCT07486089
What this trial is testing

Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)HER2-positive Breast CancerTriple-Negative Breast Cancer (TNBC)
Beijing Biotech 60
Next Page